HCC70: Human Triple Negative Mammary Carcinoma
(actual study data; representative)
Parameter
Information
Strain
NSG
Implant Type
Cells
Implant Location
SC, High Axila
Time to Staging
17 days
Time to 750mm3
47.2 days
Td
14.8 days
(The above parameters are from one study. For further information on this cell line and other parameters, including different strains, vendors, implant type and location and/or standards of care, please contact MI Bioresearch.)
Histotype: Mammary/Breast
Tumor Line: Human
REF# 2560
Related Information:
Focal Radiation Enhances Paclitaxel Therapy in a Mouse Model of Triple Negative Breast Cancer